Skip to main content

Table 2 Baseline characteristics of patients with PVCs/IVT originating from the Tricuspid annulus

From: Idiopathic premature ventricular contractions and ventricular tachycardias originating from the vicinity of tricuspid annulus: Results of radiofrequency catheter ablation in thirty-five patients

Patient

Sex

Age (years)

PVCs/IVT

AADs used

PVC count (No /24 h)

LVEF

Mapping technique

EAT (ms)

1

M

18

PVCs

beta-blocker,Propafenone

21862

62

pace

NA

2

M

18

PVCs

beta-blocker,Propafenone, Mexiletine

19862

69

Pace

NA

3

F

46

PVCs

beta-blocker,Propafenone, Mexiletine

30237

65

EAT + Pace

33

4

M

19

PVCs

beta-blocker,Propafenone, Mexiletine

16804

69

Pace

NA

5

M

67

PVCs

beta-blocker,Propafenone, Mexiletine

16237

62

EAT + Pace

34

6

M

57

PVCs

beta-blocker,Propafenone

22356

51

EAT + Pace

32

7

F

32

PVCs

beta-blocker,Propafenone, Mexiletine

33672

68

EAT + Pace

41

8

F

22

PVCs/NSVT

beta-blocker,Propafenone, Mexiletine

28136

70

EAT + Pace

33

9

F

19

PVCs

beta-blocker,Propafenone, Mexiletine

37691

69

EAT + Pace

32

10

M

32

PVCs

beta-blocker,Propafenone, Mexiletine,Amiodarone

24686

56

Pace

NA

11

M

21

PVCs

beta-blocker,Propafenone, Mexiletine

10086

67

EAT + Pace

30

12

M

14

PVCs

beta-blocker,Propafenone, Mexiletine

36338

68

EAT + Pace

30

13

M

60

PVCs

beta-blocker,Propafenone, Mexiletine

16401

58

EAT + Pace

41

14

F

25

PVCs

beta-blocker,Propafenone

11027

67

EAT + Pace

31

15

M

64

PVCs/NSVT

beta-blocker,Propafenone, Mexiletine,Amiodarone

18511

56

EAT + Pace

35

16

F

23

PVCs

beta-blocker,Propafenone, Mexiletine

18565

71

EAT + Pace

28

17

M

32

PVCs

beta-blocker,Propafenone, Mexiletine

22320

62

EAT + Pace

28

18

M

17

PVCs/NSVT

beta-blocker,Propafenone, Mexiletine

31412

68

EAT + Pace

35

19

M

63

PVCs

beta-blocker,Propafenone

21127

65

EAT + Pace

30

20

M

69

SVT/PVCs

beta-blocker,Propafenone,Amiodarone

19863

52

EAT + Pace

30

21

M

58

SVT/PVCs

Propafenone

20051

61

Pace

NA

22

F

24

PVCs

beta-blocker,Propafenone

21074

68

EAT + Pace

32

23

M

70

PVCs

beta-blocker,Propafenone

17684

62

EAT + Pace

36

24

F

66

PVCs

beta-blocker,Propafenone, Mexiletine

18280

66

EAT + Pace

28

25

M

33

PVCs

beta-blocker,Propafenone

23873

65

EAT + Pace

33

26

F

14

PVCs

beta-blocker,Propafenone

27693

52

EAT + Pace

31

27

M

19

PVCs

beta-blocker,Propafenone,Amiodarone

24132

71

EAT + Pace

31

28

F

50

PVCs

beta-blocker,Propafenone,Amiodarone

17892

54

EAT + Pace

32

29

M

49

PVCs

beta-blocker, Amiodarone

10873

63

Pace

NA

30

F

17

PVCs

beta-blocker,Mexiletine

36817

68

EAT + Pace

30

31

F

23

PVCs

beta-blocker,Propafenone

16382

62

EAT + Pace

32

32

M

58

PVCs

beta-blocker,Propafenone,Amiodarone

10005

64

Pace

NA

33

M

17

PVCs

beta-blocker,Propafenone

13761

71

EAT + Pace

41

34

F

59

PVCs

beta-blocker,Mexiletine

17219

56

EAT + Pace

24

35

M

17

PVCs

beta-blocker,Propafenone

20174

68

EAT + Pace

31

mean ± SD

 

36.91 ±19.98

  

21517 ±7429

63.6 ±5.91

 

32.29  ± 3.93

  1. AADs = antiarrhythmic drugs, LVEF = left ventricular ejection fraction, EAT, the earliest ventricular activation time recorded at ablation target sites that preceded the onset of the QRS complex.